Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection

The purpose of this study is to evaluate, treat and follow patients with parasitic infections.

Contact Information

Office/Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)
Phone: 800-411-1222
TTY: TTY dial 711
Email: ccopr@nih.gov
 

Admission and Management of Occupational or Other Exposures to Biodefense/Bioterrorism Agents or to Epidemic/Emerging Infectious Diseases

The objective of this study is to apply standardized, documented, and carefully monitored evaluation and treatment methods for bioterrorism- and biodefense-related illnesses and emerging infectious diseases at the National Institutes of Health Clinical Center.

Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)

This protocol will assess the safety of belimumab in Idiopathic CD4 lymphopenia (ICL) and also help in better understanding the role of autoantibodies in ICL pathogenesis. This knowledge could substantially improve rationale and design of novel therapeutic interventions in ICL.

Contact Information

Office/Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)
Phone: 800-411-1222
TTY: TTY8664111010
Email: prpl@cc.nih.gov
 

HIV Outpatient Monitoring Evaluation Through Self-collection of Dried Blood Spots

The goal of this observational study is to establish an operational framework for home self-collections of blood samples to be used for antiviral drug concentration measurements.

Contact Information

Office/Contact: Ryan Coyle, MPH
Phone: 720-695-8020
Email: ryan.coyle@cuanschutz.edu
 

Tissue Biopsy and Imaging Studies in HIV-Infected Patients

The purpose of this study is to examine tissue from the tonsils, lymph nodes and large bowel of HIV-infected patients to investigate changes in viral load and certain white blood cells during treatment.

Contact Information

Office/Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)
Phone: 800-411-1222
TTY: TTY dial 711
Email: ccopr@nih.gov
 

A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression

The purpose of this study is to investigate FE and its genetic causes, damage mechanisms, and disease markers (such as blood test abnormalities).

Contact Information

Office/Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)
Phone: 800-411-1222
TTY: TTY dial 711
Email: ccopr@nih.gov
 

Paired Marrow Aspirations to Assess Assays in Sensitized Renal Allograft Recipients

The aim of this study is to determine a comprehensive immune profile of transplant donors and recipients through assessment of immune cell compositions in bone marrow, and lymph nodes.

Contact Information

Office/Contact: Nong Yowe Braaten
Phone: 507-538-9617
 

A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

The purpose of this study is to evaluate whether Mozobil is safe and effective to treat neutropenia (low white blood cell count) in patients with WHIMS and to determine an appropriate treatment dose of Mozobil, within currently approved dosage levels.

Contact Information

Office/Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)
Phone: 800-411-1222
TTY: TTY dial 711
Email: ccopr@nih.gov
 

Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)

The purpose of this study is to see if signs of inflammation in CSF help predict a persons response to different drugs.

Contact Information

Office/Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)
Phone: 800-411-1222
TTY: TTY8664111010
Email: prpl@cc.nih.gov
 

Training Protocol on the Natural History of Tuberculosis

The objective of this study is to collect blood and other samples to study the natural history of tuberculosis.

Contact Information

Office/Contact: Carla Williams, B.S.N.
Phone: 301-443-9460
Email: williamscd@mail.nih.gov
 

Subscribe to Therapeutics